IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,441,549 | +289.6% | 75,991 | +218.5% | 0.01% | +400.0% |
Q1 2023 | $370,007 | +16.4% | 23,856 | -58.2% | 0.00% | 0.0% |
Q3 2022 | $318,000 | +29.3% | 57,027 | -9.5% | 0.00% | – |
Q2 2022 | $246,000 | -21.9% | 63,047 | +10.4% | 0.00% | – |
Q1 2022 | $315,000 | -56.1% | 57,110 | -32.2% | 0.00% | -100.0% |
Q4 2021 | $718,000 | +3.5% | 84,294 | +5.6% | 0.00% | 0.0% |
Q3 2021 | $694,000 | +109.7% | 79,812 | +155.3% | 0.00% | – |
Q2 2021 | $331,000 | +114.9% | 31,268 | +224.8% | 0.00% | – |
Q1 2021 | $154,000 | – | 9,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |